Association of genetic polymorphisms in HTR3A and HTR3E with diarrhea predominant irritable bowel syndrome

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 4581-4585

  Gu, Qiao Yan ^a,b   Zhang, Jun ^a   Feng, Yi Chao ^b   Dai, Guang Rong ^b   Du, Wei Ping ^b  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b YAN'AN UNIVERSITY   (China)

Author keywords

Diarrhea predominant irritable bowel syndrome; Gene; HTR3A; HTR3E; Polymorphism

Indexed keywords

GENOMIC DNA;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIARRHEA; DNA SEQUENCE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HTR3A GENE; HTR3E GENE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84929359368     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. [1] Vanuytsel T, Tack JF, Boeckxstaens GE. Tre-atment of abdominal pain in irritable bowel syndrome. J Gastroenterol 2014; 49: 1193-205.
2. [2] Camilleri M. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother 2013; 14: 1151-60.
3. [3] Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 991-1000.
4. [4] Zhan DW, Sun JH, Luo KT, Xu LZ, Zhou JL, Pei LX, Chen L, Wu XL, Zhang JW, Zhang W, Jiao DY, Zhu L. Effects and efficacy observation of acupuncture on serum 5-HT in patients with diarrhea-predominant irritable bowel syndrome. Zhongguo Zhen Jiu 2014; 34: 135-8.
5. [5] Itagaki R, Koda K, Yamazaki M, Shuto K, Kosugi C, Hirano A, Arimitsu H, Shiragami R, Yoshimura Y, Suzuki M. Serotonin (5-HT3) receptor antagonists for the reduction of symptoms of low anterior resection syndrome. Clin Exp Gastroenterol 2014; 7: 47-52.
6. [6] Barbara G. Revival of 5-HT3 antagonism as treatment of IBS-D? Gut 2014; 63: 1530-2.
7. [7] Kapeller J, Möller D, Lasitschka F, Autschbach F, Hovius R, Rappold G, Brüss M, Gershon MD, Niesler B. Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT-3E. J Comp Neurol 2011; 519: 420-32.
8. [8] Schuhmacher A, Mössner R, Quednow BB, Kühn KU, Wagner M, Cvetanovska G, Rujescu D, Zill P, Möller HJ, Rietschel M, Franke P, Wölwer W, Gaebel W, Maier W. Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Pharmacogenet Genomics 2009; 19: 843-51
9. [9] Montagnana M, Danese E, Lippi G. Genetic risk factors of atherothrombosis. Pol Arch Med Wewn 2014; 124: 474-82.
10. [10] Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, Bueller JA, Suyenobu B, Jarcho JM, McRoberts JA, Niesler B, Mayer EA. The HTR3A polymorphism c. -42C> T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology 2011; 140: 1943-51.
11. [11] Zhang Y, Huang Y, Bo P. Association between diarrhea-predominant irritable bowel syndrome and HTR3A, HTR3E gene polymorphism in Yangzhou, Jiangsu province, China. Zhong-hua Liu Xing Bing Xue Za Zhi 2013; 34: 721-4.
12. [12] Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
13. [13] Scanu AM1, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J. Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn’s disease and Johne’s disease: common neural and immune pathogenicities. J Clin Microbiol 2007; 45: 3883-90.
14. [14] Canavan C, Card T, West J. The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study. PLoS One 2014; 9: e106478.
15. [15] Herman J, Pokkunuri V, Braham L, Pimentel M. Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea. Gend Med 2010; 7: 240-6
16. [16] Okumura T. Brain-gut interaction in the pathophysiology of IBS. Nihon Shokakibyo Gakkai Zasshi 2014; 111: 1334-44.
17. [17] De Palma G, Collins SM, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 2014; 5: 419-29.
18. [18] Saletu-Zyhlarz GM, Anderer P, Arnold O, Saletu B. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depre-ssed outpatients. Neuropsychobiology 2003; 48: 194-208.
19. [19] Kapeller J, Houghton LA, Mönnikes H, Walstab J, Möller D, Bönisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N, Fischer C, Whorwell PJ, Atkinson W, Fell C, Büchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008; 17: 2967-77.
20. [20] Niesler B, Flohr T, Nöthen MM, Fischer C, Rietschel M, Franzek E, Albus M, Propping P, Rappold GA. Association between the 5’ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Phar-macogenetics 2001; 11: 471-5.
21. [21] Iidaka T, Ozaki N, Matsumoto A, Nogawa J, Kinoshita Y, Suzuki T, Iwata N, Yamamoto Y, Okada T, Sadato N. A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J Neurosci 2005; 25: 6460-6.